ACE Program Management & Optimization 3

Question 1

A 340B program manager is reviewing quarterly utilization reports and notices a significant drop in 340B capture rate. What is the most appropriate first step?

Accepted Answer

Analyze claims data to identify where eligible prescriptions are being missed

Answer

Analyzing claims data is the foundational step to identify gaps in eligibility identification, dispensing workflows, or data accumulation before implementing solutions.

Question 2

Which of the following best describes the 'accumulation' step in a 340B contract pharmacy model?

Accepted Answer

The tracking and crediting of 340B-eligible prescriptions dispensed at a contract pharmacy

Answer

Accumulation refers to identifying 340B-eligible prescriptions dispensed at a contract pharmacy and building a replenishment credit that the covered entity uses to reorder drugs at 340B pricing.

Question 3

Under Apexus guidelines, which factor most directly determines whether a patient qualifies as a '340B patient' for an outpatient clinic encounter?

Accepted Answer

Whether the covered entity has a healthcare relationship with the patient and is responsible for their care

Answer

The 340B patient definition requires that the covered entity have an established healthcare relationship with the patient and maintain responsibility for that patient's care.

Question 4

A hospital's 340B program is being expanded to include an off-site clinic. What is the required action before the clinic can participate in 340B drug purchases?

Accepted Answer

Register the child site with HRSA during an open enrollment period

Answer

Off-site outpatient facilities must be registered with HRSA as child sites during an enrollment period before they are eligible to participate in 340B drug purchasing.

Question 5

Which internal control is most effective at preventing 340B drug diversion to ineligible patients?

Accepted Answer

Implementing a robust patient eligibility verification process at the point of prescribing

Answer

Verifying patient eligibility at the point of prescribing ensures that 340B drugs are reserved for patients who meet the program definition, the most upstream and effective control.

(ACE) Apexus Certified Expert Practice Test

(ACE) Apexus Certified Expert Practice Test

ACE Program Management & Optimization 3